Oreofe O Odejide

Oreofe O Odejide

UNVERIFIED PROFILE

Are you Oreofe O Odejide?   Register this Author

Register author
Oreofe O Odejide

Oreofe O Odejide

Publications by authors named "Oreofe O Odejide"

Are you Oreofe O Odejide?   Register this Author

23Publications

552Reads

14Profile Views

Goals of care discussions for patients with blood cancers: Association of person, place, and time with end-of-life care utilization.

Cancer 2020 Feb 8;126(3):515-522. Epub 2019 Oct 8.

Division of Population Sciences, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.32549DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6980246PMC
February 2020

Perspectives Regarding Hospice Services and Transfusion Access: Focus Groups with Blood Cancer Patients and Bereaved Caregivers.

J Pain Symptom Manage 2020 Jan 9. Epub 2020 Jan 9.

Harvard Medical School, Boston, MA; Division of Population Sciences, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jpainsymman.2019.12.373DOI Listing
January 2020

How Do Blood Cancer Doctors Discuss Prognosis? Findings from a National Survey of Hematologic Oncologists.

J Palliat Med 2019 Jun 23;22(6):677-684. Epub 2019 Mar 23.

1 Division of Population Sciences, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.

View Article

Download full-text PDF

Source
https://www.liebertpub.com/doi/10.1089/jpm.2018.0441
Publisher Site
http://dx.doi.org/10.1089/jpm.2018.0441DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6533786PMC
June 2019

Meaningful changes in end-of-life care among patients with myeloma.

Haematologica 2018 08 10;103(8):1380-1389. Epub 2018 May 10.

Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2018.187609DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6068022PMC
August 2018

Financial Hardship after Hematopoietic Cell Transplantation: Lack of Impact on Survival.

Cancer Epidemiol Biomarkers Prev 2018 03 13;27(3):345-347. Epub 2018 Feb 13.

Division of Population Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-17-1040DOI Listing
March 2018

Why are patients with blood cancers more likely to die without hospice?

Cancer 2017 Sep 22;123(17):3377-3384. Epub 2017 May 22.

Division of Population Sciences, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.30735DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5568951PMC
September 2017

Barriers to Quality End-of-Life Care for Patients With Blood Cancers.

J Clin Oncol 2016 09 11;34(26):3126-32. Epub 2016 Jul 11.

Oreofe O. Odejide, Angel M. Cronin, Nolan B. Condron, Sean A. Fletcher, James A. Tulsky, Gregory A. Abel, Dana-Farber Cancer Institute; James A. Tulsky, Brigham and Women's Hospital, Boston, MA; and Craig C. Earle, Ontario Institute for Cancer Research, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.67.8177DOI Listing
September 2016

Financial Hardship and Patient-Reported Outcomes after Hematopoietic Cell Transplantation.

Biol Blood Marrow Transplant 2016 08 13;22(8):1504-1510. Epub 2016 May 13.

Division of Hematologic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2016.05.008DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4949125PMC
August 2016

The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice.

Authors:
Elizabeth C Townsend Mark A Murakami Alexandra Christodoulou Amanda L Christie Johannes Köster Tiffany A DeSouza Elizabeth A Morgan Scott P Kallgren Huiyun Liu Shuo-Chieh Wu Olivia Plana Joan Montero Kristen E Stevenson Prakash Rao Raga Vadhi Michael Andreeff Philippe Armand Karen K Ballen Patrizia Barzaghi-Rinaudo Sarah Cahill Rachael A Clark Vesselina G Cooke Matthew S Davids Daniel J DeAngelo David M Dorfman Hilary Eaton Benjamin L Ebert Julia Etchin Brant Firestone David C Fisher Arnold S Freedman Ilene A Galinsky Hui Gao Jacqueline S Garcia Francine Garnache-Ottou Timothy A Graubert Alejandro Gutierrez Ensar Halilovic Marian H Harris Zachary T Herbert Steven M Horwitz Giorgio Inghirami Andrew M Intlekofer Moriko Ito Shai Izraeli Eric D Jacobsen Caron A Jacobson Sébastien Jeay Irmela Jeremias Michelle A Kelliher Raphael Koch Marina Konopleva Nadja Kopp Steven M Kornblau Andrew L Kung Thomas S Kupper Nicole R LeBoeuf Ann S LaCasce Emma Lees Loretta S Li A Thomas Look Masato Murakami Markus Muschen Donna Neuberg Samuel Y Ng Oreofe O Odejide Stuart H Orkin Rachel R Paquette Andrew E Place Justine E Roderick Jeremy A Ryan Stephen E Sallan Brent Shoji Lewis B Silverman Robert J Soiffer David P Steensma Kimberly Stegmaier Richard M Stone Jerome Tamburini Aaron R Thorner Paul van Hummelen Martha Wadleigh Marion Wiesmann Andrew P Weng Jens U Wuerthner David A Williams Bruce M Wollison Andrew A Lane Anthony Letai Monica M Bertagnolli Jerome Ritz Myles Brown Henry Long Jon C Aster Margaret A Shipp James D Griffin David M Weinstock

Cancer Cell 2016 07 11;30(1):183. Epub 2016 Jul 11.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ccell.2016.06.008DOI Listing
July 2016

Influence of patient and provider characteristics on quality of care for the myelodysplastic syndromes.

Br J Haematol 2016 06 23;173(5):713-21. Epub 2016 Feb 23.

Center for Leukemia, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.13987DOI Listing
June 2016

The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice.

Authors:
Elizabeth C Townsend Mark A Murakami Alexandra Christodoulou Amanda L Christie Johannes Köster Tiffany A DeSouza Elizabeth A Morgan Scott P Kallgren Huiyun Liu Shuo-Chieh Wu Olivia Plana Joan Montero Kristen E Stevenson Prakash Rao Raga Vadhi Michael Andreeff Philippe Armand Karen K Ballen Patrizia Barzaghi-Rinaudo Sarah Cahill Rachael A Clark Vesselina G Cooke Matthew S Davids Daniel J DeAngelo David M Dorfman Hilary Eaton Benjamin L Ebert Julia Etchin Brant Firestone David C Fisher Arnold S Freedman Ilene A Galinsky Hui Gao Jacqueline S Garcia Francine Garnache-Ottou Timothy A Graubert Alejandro Gutierrez Ensar Halilovic Marian H Harris Zachary T Herbert Steven M Horwitz Giorgio Inghirami Andrew M Intlekofer Moriko Ito Shai Izraeli Eric D Jacobsen Caron A Jacobson Sébastien Jeay Irmela Jeremias Michelle A Kelliher Raphael Koch Marina Konopleva Nadja Kopp Steven M Kornblau Andrew L Kung Thomas S Kupper Nicole R LeBoeuf Ann S LaCasce Emma Lees Loretta S Li A Thomas Look Masato Murakami Markus Muschen Donna Neuberg Samuel Y Ng Oreofe O Odejide Stuart H Orkin Rachel R Paquette Andrew E Place Justine E Roderick Jeremy A Ryan Stephen E Sallan Brent Shoji Lewis B Silverman Robert J Soiffer David P Steensma Kimberly Stegmaier Richard M Stone Jerome Tamburini Aaron R Thorner Paul van Hummelen Martha Wadleigh Marion Wiesmann Andrew P Weng Jens U Wuerthner David A Williams Bruce M Wollison Andrew A Lane Anthony Letai Monica M Bertagnolli Jerome Ritz Myles Brown Henry Long Jon C Aster Margaret A Shipp James D Griffin David M Weinstock

Cancer Cell 2016 04;29(4):574-586

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, 450 Brookline Avenue, Dana 510B, MA 02215, USA; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ccell.2016.03.008DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5177991PMC
April 2016

Timeliness of End-of-Life Discussions for Blood Cancers: A National Survey of Hematologic Oncologists.

JAMA Intern Med 2016 Feb;176(2):263-5

Division of Population Sciences, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts5Center for Leukemia, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamainternmed.2015.6599DOI Listing
February 2016

Hospice Use Among Patients With Lymphoma: Impact of Disease Aggressiveness and Curability.

J Natl Cancer Inst 2016 Jan 5;108(1). Epub 2015 Oct 5.

Division of Population Sciences (OOO, AMC, GAA), Center for Lymphoma (OOO, ASL), and Center for Leukemia (GAA), Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA; Ontario Institute for Cancer Research, Toronto, Canada (CCE).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djv280DOI Listing
January 2016

A Policy Prescription for Hospice Care.

Authors:
Oreofe O Odejide

JAMA 2016 Jan;315(3):257-8

Division of Population Sciences, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jama.2015.18424DOI Listing
January 2016

Limited stage diffuse large B-cell lymphoma: comparative effectiveness of treatment strategies in a large cohort of elderly patients.

Leuk Lymphoma 2015 Mar 6;56(3):716-24. Epub 2014 Aug 6.

Division of Population Sciences, Dana-Farber Cancer Institute , Boston, MA , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2014.930853DOI Listing
March 2015

End-of-life care for blood cancers: a series of focus groups with hematologic oncologists.

J Oncol Pract 2014 Nov 7;10(6):e396-403. Epub 2014 Oct 7.

Dana-Farber Cancer Institute and University of Massachusetts Boston, Boston, MA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.2014.001537DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5706135PMC
November 2014

Early lymphoid lesions: conceptual, diagnostic and clinical challenges.

Haematologica 2014 Sep;99(9):1421-32

Hematopathology Section, Center for Cancer Research, Laboratory of Pathology, National Cancer Institute, Harvard Medical School, Boston, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2014.107938DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4562530PMC
September 2014

Reply to quality control of bone marrow aspirates: additional steps toward a safer and more efficient procedure.

Cancer 2014 May 30;120(9):1442. Epub 2014 Jan 30.

Division of Population Sciences, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.28603DOI Listing
May 2014

Improving the quality of bone marrow assessment: Impact of operator techniques and use of a specimen preparation checklist.

Cancer 2013 Oct 6;119(19):3472-8. Epub 2013 Aug 6.

Division of Population Sciences, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.28249DOI Listing
October 2013

An extreme example of focal bone marrow involvement in acute myeloid leukemia.

Am J Hematol 2013 Apr 31;88(4):335-6. Epub 2012 Oct 31.

Christ Church, University of Oxford, Oxford, United Kingdom.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/ajh.23350
Publisher Site
http://dx.doi.org/10.1002/ajh.23350DOI Listing
April 2013

Survival of a patient with anaplastic thyroid cancer following intensity-modulated radiotherapy and sunitinib--a case report.

Anticancer Res 2012 May;32(5):1743-6

Harvard Radiation Oncology Program, and Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114, USA.

View Article

Download full-text PDF

Source
May 2012